North America Epilepsy Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)

No. of Pages: 135
Report Code: BMIRE00030781
Category: Life Sciences
North America Epilepsy Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Epilepsy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Epilepsy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Epilepsy Market Regional Analysis

6.2 North America Epilepsy Market Revenue 2020-2030 (US$ Million)
6.3 North America Epilepsy Market Forecast Analysis

7. North America Epilepsy Market Analysis – by Type

7.1 Progressive Myoclonic Epilepsy
  • 7.1.1 Overview
  • 7.1.2 Progressive Myoclonic Epilepsy: North America Epilepsy Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Reflex Epilepsy
  • 7.2.1 Overview
  • 7.2.2 Reflex Epilepsy: North America Epilepsy Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Generalized Epilepsy
  • 7.3.1 Overview
  • 7.3.2 Generalized Epilepsy: North America Epilepsy Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Epilepsy Market Analysis – by Route of Administration

8.1 Oral
  • 8.1.1 Overview
  • 8.1.2 Oral: North America Epilepsy Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Parenteral
  • 8.2.1 Overview
  • 8.2.2 Parenteral: North America Epilepsy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Epilepsy Market Analysis – by Age Group

9.1 Adult and Children
  • 9.1.1 Overview
  • 9.1.2 Adult and Children: North America Epilepsy Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Epilepsy Market – North America Analysis

10.1 Overview

10.2 North America
  • 10.2.1 North America Epilepsy Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.2.1.1 North America Epilepsy Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 US: North America Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.1.1 US: North America Epilepsy Market Breakdown, by Type
    • 10.2.1.1.2 US: North America Epilepsy Market Breakdown, by Route of Administration
    • 10.2.1.1.3 US: North America Epilepsy Market Breakdown, by Age Group
  • 10.2.1.2 Canada: North America Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.2.1 Canada: North America Epilepsy Market Breakdown, by Type
    • 10.2.1.2.2 Canada: North America Epilepsy Market Breakdown, by Route of Administration
    • 10.2.1.2.3 Canada: North America Epilepsy Market Breakdown, by Age Group
  • 10.2.1.3 Mexico : North America Epilepsy Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.3.1 Mexico : North America Epilepsy Market Breakdown, by Type
    • 10.2.1.3.2 Mexico : North America Epilepsy Market Breakdown, by Route of Administration
    • 10.2.1.3.3 Mexico : North America Epilepsy Market Breakdown, by Age Group

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Pfizer Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Eisai Co Ltd
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 UCB SA
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 LivaNova Plc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Novartis AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Medtronic Plc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 GSK Plc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 H. Lundbeck AS
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - North America Epilepsy Market

  • Abbott Laboratories
  • Pfizer Inc
  • Eisai Co Ltd
  • UCB SA
  • LivaNova Plc
  • Novartis AG
  • Medtronic Plc
  • GSK Plc
  • H. Lundbeck AS

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)